Missing out on effective care in idiopathic pulmonary fibrosis: Racial inequality in access to anti-fibrotic therapy

被引：0
|
作者：
Pascoe, Amy [1 ]
Smallwood, Natasha [1 ,2 ]
机构：
[1] Monash Univ, Cent Clin Sch, Resp Res, Alfred, Vic, Australia
[2] Alfred Hosp, Dept Resp & Sleep Med, Prahran, Vic, Australia
来源：
RESPIROLOGY | 2023年 / 28卷 / 11期
关键词：
antifibrotic agents; health disparities; health inequities; idiopathic pulmonary fibrosis; interstitial lung disease; mortality; social determinants of health; DISPARITIES; COPD;
D O I：
10.1111/resp.14594
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
See related article
引用
收藏
页码：978 / 979
页数：2
相关论文
共 35 条
  • [31] Pulmonologists' Perspectives on and Access to Palliative Care for Patients With Idiopathic Pulmonary Fibrosis in South Carolina
    Lindell, Kathleen Oare
    Madisetti, Mohan
    Fasolino, Tracy
    Pittman, MaryChris
    Coyne, Patrick
    Whelan, Timothy P. M.
    Mueller, Martina
    Ford, Dee W.
    PALLIATIVE MEDICINE REPORTS, 2023, 4 (01): : 292 - 299
  • [32] Phosphonothioamidate in Bleomycin-Induced Pulmonary Fibrosis in Rats: Experimental Anti-Fibrotic Assessment, Theoretical DFT Calculations and Molecular Docking Study
    Bahri, S.
    Omrani, R.
    Jebli, N.
    Nahdi, A.
    Mlika, M.
    El Ouederni, A. R.
    Jameleddine, S.
    Ben Ali, R.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2023, 49 (04) : 836 - 848
  • [33] Phosphonothioamidate in Bleomycin-Induced Pulmonary Fibrosis in Rats: Experimental Anti-Fibrotic Assessment, Theoretical DFT Calculations and Molecular Docking Study
    S. Bahri
    R. Omrani
    N. Jebli
    A. Nahdi
    M. Mlika
    A.R. El Ouederni
    S. Jameleddine
    R. Ben Ali
    Russian Journal of Bioorganic Chemistry, 2023, 49 : 836 - 848
  • [34] Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care
    Antoniou, Katerina M.
    Tsitoura, Eliza
    Vasarmidi, Eirini
    Symvoulakis, Emmanouil K.
    Aidinis, Vassilis
    Tzilas, Vassilis
    Tzouvelekis, Argyris
    Bouros, Demosthenes
    CURRENT OPINION IN PHARMACOLOGY, 2021, 57 : 71 - 80
  • [35] PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced idiopathic pulmonary fibrosis by regulation of extracellular matrix remodelling
    Gagnon, Lyne
    Sarra-Bournet, Francois
    Tremblay, Mikael
    Doucet, Andre
    Felton, Alexandra
    Leduc, Martin
    Laurin, Pierre
    Grouix, Brigitte
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
1234